Results 201 to 210 of about 524,795 (331)
A nucleotide‐independent, pan‐RAS‐targeted DARPin elicits anti‐tumor activity in a multimodal manner
We report a Designed Ankyrin Repeat Protein that binds and inhibits RAS proteins, which serve as central cell signaling hubs and are essential for the progression of many cancers. Its unique feature is that it does not discriminate between different RAS isoforms or mutations and is capable of binding to RAS in both its active (GTP‐bound) and inactive ...
Jonas N. Kapp+13 more
wiley +1 more source
A Technological Review of Digital Twins and Artificial Intelligence for Personalized and Predictive Healthcare. [PDF]
Chaparro-Cárdenas SL+6 more
europepmc +1 more source
Comments on the Analysis of Twin Samples—II. The Sample [PDF]
Gordon Allen
openalex +1 more source
Twins twin transfusion syndrome in monochorionic twins [PDF]
Orcid https: Mohamed W Gawish+2 more
openaire +2 more sources
C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald+18 more
wiley +1 more source
Woman with term presentation of acaridac twin pregnancy with three cesarean section scars: a case report. [PDF]
Dinsa LH, Hailu AM, Eticha AD.
europepmc +1 more source
Unraveling LINE‐1 retrotransposition in head and neck squamous cell carcinoma
The novel RetroTest method allows the detection of L1 activation in clinical samples with low DNA input, providing global L1 activity and the identification of the L1 source element. We applied RetroTest to a real‐world cohort of HNSCC patients where we reported an early L1 activation, with more than 60% of T1 patients showing L1 activity.
Jenifer Brea‐Iglesias+12 more
wiley +1 more source
The geo-politics of resilience: On the historical convergence between ecology, artificial intelligence, and corporate strategy. [PDF]
Halpern O.
europepmc +1 more source